Author
Listed:
- Susan E. Logue
(National University of Ireland Galway
National University of Ireland Galway)
- Eoghan P. McGrath
(National University of Ireland Galway
National University of Ireland Galway)
- Patricia Cleary
(National University of Ireland Galway
National University of Ireland Galway)
- Stephanie Greene
(Fosun Orinove PharmaTech Inc.)
- Katarzyna Mnich
(National University of Ireland Galway
National University of Ireland Galway)
- Aitor Almanza
(National University of Ireland Galway
National University of Ireland Galway)
- Eric Chevet
(Université de Rennes 1
Centre de Lutte Contre le Cancer Eugène Marquis)
- Róisín M. Dwyer
(National University of Ireland Galway)
- Anup Oommen
(National University of Ireland Galway)
- Patrick Legembre
(Université de Rennes 1
Centre de Lutte Contre le Cancer Eugène Marquis)
- Florence Godey
(Université de Rennes 1
Centre de Lutte Contre le Cancer Eugène Marquis)
- Emma C. Madden
(National University of Ireland Galway
National University of Ireland Galway)
- Brian Leuzzi
(National University of Ireland Galway
National University of Ireland Galway)
- Joanna Obacz
(Université de Rennes 1
Centre de Lutte Contre le Cancer Eugène Marquis)
- Qingping Zeng
(Fosun Orinove PharmaTech Inc.)
- John B. Patterson
(Fosun Orinove PharmaTech Inc.)
- Richard Jäger
(University of Applied Sciences, Department of Natural Sciences)
- Adrienne M. Gorman
(National University of Ireland Galway
National University of Ireland Galway)
- Afshin Samali
(National University of Ireland Galway
National University of Ireland Galway)
Abstract
Triple-negative breast cancer (TNBC) lacks targeted therapies and has a worse prognosis than other breast cancer subtypes, underscoring an urgent need for new therapeutic targets and strategies. IRE1 is an endoplasmic reticulum (ER) stress sensor, whose activation is predominantly linked to the resolution of ER stress and, in the case of severe stress, to cell death. Here we demonstrate that constitutive IRE1 RNase activity contributes to basal production of pro-tumorigenic factors IL-6, IL-8, CXCL1, GM-CSF, and TGFβ2 in TNBC cells. We further show that the chemotherapeutic drug, paclitaxel, enhances IRE1 RNase activity and this contributes to paclitaxel-mediated expansion of tumor-initiating cells. In a xenograft mouse model of TNBC, inhibition of IRE1 RNase activity increases paclitaxel-mediated tumor suppression and delays tumor relapse post therapy. We therefore conclude that inclusion of IRE1 RNase inhibition in therapeutic strategies can enhance the effectiveness of current chemotherapeutics.
Suggested Citation
Susan E. Logue & Eoghan P. McGrath & Patricia Cleary & Stephanie Greene & Katarzyna Mnich & Aitor Almanza & Eric Chevet & Róisín M. Dwyer & Anup Oommen & Patrick Legembre & Florence Godey & Emma C. Ma, 2018.
"Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy,"
Nature Communications, Nature, vol. 9(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05763-8
DOI: 10.1038/s41467-018-05763-8
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Michael J. P. Crowley & Bhavneet Bhinder & Geoffrey J. Markowitz & Mitchell Martin & Akanksha Verma & Tito A. Sandoval & Chang-Suk Chae & Shira Yomtoubian & Yang Hu & Sahil Chopra & Diamile A. Tavarez, 2023.
"Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer,"
Nature Communications, Nature, vol. 14(1), pages 1-16, December.
- Aitor Almanza & Katarzyna Mnich & Arnaud Blomme & Claire M. Robinson & Giovanny Rodriguez-Blanco & Sylwia Kierszniowska & Eoghan P. McGrath & Matthieu Gallo & Eleftherios Pilalis & Johannes V. Swinnen, 2022.
"Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer,"
Nature Communications, Nature, vol. 13(1), pages 1-13, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05763-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.